163 related articles for article (PubMed ID: 35275744)
1. Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?
Hershlag A; Mullin C; Bristow SL
JCO Glob Oncol; 2020 Nov; 6():356-359. PubMed ID: 35275744
[No Abstract] [Full Text] [Related]
2. Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?
Hershlag A; Mullin C; Bristow SL
JCO Glob Oncol; 2020; 6():. PubMed ID: 32259161
[No Abstract] [Full Text] [Related]
3. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation before neoadjuvant chemotherapy in a premenopausal breast cancer patient: a case report.
Kobayashi A; Matsunuma R; Yamaguchi K; Hayami R; Tsuneizumi M; Nakagami K
Oxf Med Case Reports; 2019 Nov; 2019(11):473-475. PubMed ID: 31844530
[TBL] [Abstract][Full Text] [Related]
5. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
7. Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report.
Cheng J; Ruan X; Du J; Jin F; Li Y; Liu X; Wang H; Gu M; Mueck AO
J Ovarian Res; 2021 Dec; 14(1):176. PubMed ID: 34895280
[TBL] [Abstract][Full Text] [Related]
8. Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?
Crown A; Muhsen S; Zabor EC; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2020 Nov; 27(12):4740-4749. PubMed ID: 32767225
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists.
Kitano A; Shimizu C; Yamauchi H; Akitani F; Shiota K; Miyoshi Y; Ohde S
ESMO Open; 2019; 4(2):e000459. PubMed ID: 30962960
[TBL] [Abstract][Full Text] [Related]
10. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
Turan V; Bedoschi G; Moy F; Oktay K
Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
Noll F; Palacios Torres AT; Pecci P; Lucchini SM; Heredia F
Int J Gynecol Cancer; 2021 Mar; 31(3):379-386. PubMed ID: 33649005
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center.
Dieci MV; Ghiotto C; Barbieri C; Griguolo G; Saccardi C; Gangemi M; Pluchinotta A; Di Liso E; Giorgi CA; Giarratano T; Tasca G; Vernaci G; Faggioni G; Conte P; Guarneri V
J Womens Health (Larchmt); 2019 Apr; 28(4):544-550. PubMed ID: 29963941
[TBL] [Abstract][Full Text] [Related]
13. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
[TBL] [Abstract][Full Text] [Related]
14. Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues.
Park SY; Jeong K; Cho EH; Chung HW
Clin Exp Reprod Med; 2021 Mar; 48(1):1-10. PubMed ID: 33131234
[TBL] [Abstract][Full Text] [Related]
15. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
[TBL] [Abstract][Full Text] [Related]
16. Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients.
Lambertini M; Di Maio M; Poggio F; Pagani O; Curigliano G; Mastro LD; Paluch-Shimon S; Loibl S; Partridge AH; Azim HA; Peccatori FA; Demeestere I
Reprod Biomed Online; 2019 May; 38(5):835-844. PubMed ID: 30914152
[TBL] [Abstract][Full Text] [Related]
17. Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer.
Kim J; Oktay K; Gracia C; Lee S; Morse C; Mersereau JE
Fertil Steril; 2012 Mar; 97(3):671-6. PubMed ID: 22222194
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
19. Developing a Web-Based Shared Decision-Making Tool for Fertility Preservation Among Reproductive-Age Women With Breast Cancer: An Action Research Approach.
Tseng LM; Lien PJ; Huang CY; Tsai YF; Chao TC; Huang SM
J Med Internet Res; 2021 Mar; 23(3):e24926. PubMed ID: 33729164
[TBL] [Abstract][Full Text] [Related]
20. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
D'Hondt C; Vanhoeij M; Van Moer E; Segers I; Fontaine C; Tournaye H; De Vos M
Breast Cancer Res Treat; 2020 Nov; 184(2):433-444. PubMed ID: 32794060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
